Seagen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SEAGEN, and when can generic versions of SEAGEN drugs launch?
SEAGEN has one approved drug.
There are seven US patents protecting SEAGEN drugs.
There are one hundred and ninety-two patent family members on SEAGEN drugs in forty-five countries and seventeen supplementary protection certificates in fifteen countries.
Summary for Seagen
International Patents: | 192 |
US Patents: | 7 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Seagen: | See patent lawsuits for Seagen |
Drugs and US Patents for Seagen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | 9,693,989 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Seagen Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 102887891 | ⤷ Sign Up |
Canada | 3060407 | ⤷ Sign Up |
Cyprus | 1119837 | ⤷ Sign Up |
Canada | 2867723 | ⤷ Sign Up |
Mexico | 2014004551 | ⤷ Sign Up |
South Korea | 20210131426 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Seagen Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1971601 | PA2021516 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TUKATINIBAS, PASIRINKTINAI FARMACISKAI PRIIMTINOS DRUSKOS ARBA SOLVATO PAVIDALU; REGISTRATION NO/DATE: EU/1/20/1526 20210211 |
1971601 | C202130042 | Spain | ⤷ Sign Up | PRODUCT NAME: TUCATINIB, OPCIONALMENTE EN FORMA DE UNA SAL O SOLVATO ACEPTABLE; NATIONAL AUTHORISATION NUMBER: EU/1/20/1526; DATE OF AUTHORISATION: 20210211; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1526; DATE OF FIRST AUTHORISATION IN EEA: 20210211 |
1971601 | C20210018 00331 | Estonia | ⤷ Sign Up | PRODUCT NAME: TUKATINIIB;REG NO/DATE: EU/1/20/1526 12.02.2021 |
1971601 | CR 2021 00025 | Denmark | ⤷ Sign Up | PRODUCT NAME: TUCATINIB, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF; REG. NO/DATE: EU/1/20/1526 20210212 |
2765990 | 2021029 | Norway | ⤷ Sign Up | PRODUCT NAME: TUKATINIB; NAT. REG. NO/DATE: EU/1/20/1526 20210225; FIRST REG. NO/DATE: 67798 20210212 |
1971601 | 122021000042 | Germany | ⤷ Sign Up | PRODUCT NAME: TUCATINIB UND SEINE PHYSIOLOGISCH VERTRAEGLICHEN SALZE UND SOLVATE; REGISTRATION NO/DATE: EU/1/20/1526 20210211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.